TSE:4118Chemicals
Assessing Kaneka (TSE:4118) Valuation After Toro 88 Superbore Catheter FDA Clearance And US Launch
Why the Toro 88 clearance matters for Kaneka
The recent FDA 510(k) clearance and first clinical use of Toro Neurovascular’s Toro 88 Superbore Catheter brings Kaneka (TSE:4118) into focus, as Kaneka Medical America leads the product’s commercial launch in the United States.
This move strengthens Kaneka’s position in neurovascular devices, adding a new platform alongside its broader materials, medical, and nutrition businesses. It also gives investors a concrete event to reassess how the stock...